Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Cash from Investing Activities (2018 - 2023)

Avai Bio's Cash from Investing Activities history spans 5 years, with the latest figure at -$149000.0 for Q2 2023.

  • For Q2 2023, Cash from Investing Activities fell 544.64% year-over-year to -$149000.0; the TTM value through Mar 2024 reached -$149000.0, down 344.64%, while the annual FY2024 figure was -$149000.0, 344.64% down from the prior year.
  • Cash from Investing Activities for Q2 2023 was -$149000.0 at Avai Bio, down from -$67020.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $33510.0 in Q2 2022 and bottomed at -$149000.0 in Q2 2023.
  • The 4-year median for Cash from Investing Activities is -$71010.0 (2019), against an average of -$52650.2.
  • The largest annual shift saw Cash from Investing Activities tumbled 4047.37% in 2019 before it plummeted 544.64% in 2023.
  • A 4-year view of Cash from Investing Activities shows it stood at -$75000.0 in 2019, then soared by 130.43% to $22821.0 in 2020, then plummeted by 393.68% to -$67020.0 in 2022, then crashed by 122.32% to -$149000.0 in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Cash from Investing Activities are -$149000.0 (Q2 2023), -$67020.0 (Q3 2022), and $33510.0 (Q2 2022).